308 related articles for article (PubMed ID: 25946975)
1. Association of SIRT1 and tumor suppressor gene TAp63 expression in head and neck squamous cell carcinoma.
Kikuchi K; Noguchi A; Kasajima R; Miyagi Y; Hoshino D; Koshikawa N; Kubota A; Yokose T; Takano Y
Tumour Biol; 2015 Sep; 36(10):7865-72. PubMed ID: 25946975
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
He Z; Yi J; Jin L; Pan B; Chen L; Song H
Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in head and neck squamous cell carcinoma.
Kakuki T; Kurose M; Takano K; Kondoh A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Takahashi S; Hatakeyama T; Kohno T; Himi T; Kojima T
Oncotarget; 2016 Jun; 7(23):33887-900. PubMed ID: 27036044
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of SIRT gene family in head and neck squamous cell carcinoma.
Lai CC; Lin PM; Lin SF; Hsu CH; Lin HC; Hu ML; Hsu CM; Yang MY
Tumour Biol; 2013 Jun; 34(3):1847-54. PubMed ID: 23475622
[TBL] [Abstract][Full Text] [Related]
5. miR-134 induces oncogenicity and metastasis in head and neck carcinoma through targeting WWOX gene.
Liu CJ; Shen WG; Peng SY; Cheng HW; Kao SY; Lin SC; Chang KW
Int J Cancer; 2014 Feb; 134(4):811-21. PubMed ID: 23824713
[TBL] [Abstract][Full Text] [Related]
6. Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.
Kimura S; Naganuma S; Susuki D; Hirono Y; Yamaguchi A; Fujieda S; Sano K; Itoh H
Oncol Rep; 2010 Jun; 23(6):1625-33. PubMed ID: 20428818
[TBL] [Abstract][Full Text] [Related]
7. CTIP2 expression in human head and neck squamous cell carcinoma is linked to poorly differentiated tumor status.
Ganguli-Indra G; Wasylyk C; Liang X; Millon R; Leid M; Wasylyk B; Abecassis J; Indra AK
PLoS One; 2009; 4(4):e5367. PubMed ID: 19399189
[TBL] [Abstract][Full Text] [Related]
8. microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer.
Obayashi M; Yoshida M; Tsunematsu T; Ogawa I; Sasahira T; Kuniyasu H; Imoto I; Abiko Y; Xu D; Fukunaga S; Tahara H; Kudo Y; Nagao T; Takata T
Oncotarget; 2016 Feb; 7(7):8223-39. PubMed ID: 26882562
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of enhancer of zeste homolog 2 is associated positively with cyclin D1 overexpression and poor clinical outcome in head and neck squamous cell carcinoma.
Cao W; Feng Z; Cui Z; Zhang C; Sun Z; Mao L; Chen W
Cancer; 2012 Jun; 118(11):2858-71. PubMed ID: 21989926
[TBL] [Abstract][Full Text] [Related]
10. Downregulation and translocation of nuclear ING4 is correlated with tumorigenesis and progression of head and neck squamous cell carcinoma.
Li XH; Kikuchi K; Zheng Y; Noguchi A; Takahashi H; Nishida T; Masuda S; Yang XH; Takano Y
Oral Oncol; 2011 Mar; 47(3):217-23. PubMed ID: 21310648
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC).
Nohata N; Hanazawa T; Kikkawa N; Mutallip M; Sakurai D; Fujimura L; Kawakami K; Chiyomaru T; Yoshino H; Enokida H; Nakagawa M; Okamoto Y; Seki N
J Hum Genet; 2011 Aug; 56(8):595-601. PubMed ID: 21753766
[TBL] [Abstract][Full Text] [Related]
12. Lower DSC1 expression is related to the poor differentiation and prognosis of head and neck squamous cell carcinoma (HNSCC).
Wang Y; Chen C; Wang X; Jin F; Liu Y; Liu H; Li T; Fu J
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2461-2468. PubMed ID: 27601166
[TBL] [Abstract][Full Text] [Related]
13. Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma.
Bennett KL; Hackanson B; Smith LT; Morrison CD; Lang JC; Schuller DE; Weber F; Eng C; Plass C
Cancer Res; 2007 May; 67(10):4657-64. PubMed ID: 17510391
[TBL] [Abstract][Full Text] [Related]
14. Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma.
Katayama A; Ogino T; Bandoh N; Nonaka S; Harabuchi Y
Clin Cancer Res; 2005 Apr; 11(8):2937-46. PubMed ID: 15837745
[TBL] [Abstract][Full Text] [Related]
15. Expression and role of the embryonic protein SOX2 in head and neck squamous cell carcinoma.
Schröck A; Bode M; Göke FJ; Bareiss PM; Schairer R; Wang H; Weichert W; Franzen A; Kirsten R; van Bremen T; Queisser A; Kristiansen G; Heasley L; Bootz F; Lengerke C; Perner S
Carcinogenesis; 2014 Jul; 35(7):1636-42. PubMed ID: 24743512
[TBL] [Abstract][Full Text] [Related]
16. Loss of Mitochondrial Tumor Suppressor Genes Expression Is Associated with Unfavorable Clinical Outcome in Head and Neck Squamous Cell Carcinoma: Data from Retrospective Study.
Mahjabeen I; Kayani MA
PLoS One; 2016; 11(1):e0146948. PubMed ID: 26785117
[TBL] [Abstract][Full Text] [Related]
17. SIRT1 expression is associated with good prognosis for head and neck squamous cell carcinoma patients.
Noguchi A; Li X; Kubota A; Kikuchi K; Kameda Y; Zheng H; Miyagi Y; Aoki I; Takano Y
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Mar; 115(3):385-92. PubMed ID: 23453030
[TBL] [Abstract][Full Text] [Related]
18. Loss of HOP tumour suppressor expression in head and neck squamous cell carcinoma.
Lemaire F; Millon R; Muller D; Rabouel Y; Bracco L; Abecassis J; Wasylyk B
Br J Cancer; 2004 Jul; 91(2):258-61. PubMed ID: 15213722
[TBL] [Abstract][Full Text] [Related]
19. Melanoma differentiation-associated gene-7/interleukin-24 as a potential prognostic biomarker and second primary malignancy indicator in head and neck squamous cell carcinoma patients.
Wang L; Feng Z; Wu H; Zhang S; Pu Y; Bian H; Wang Y; Guo C
Tumour Biol; 2014 Nov; 35(11):10977-85. PubMed ID: 25091574
[TBL] [Abstract][Full Text] [Related]
20. Transporter gene expression in human head and neck squamous cell carcinoma and associated epigenetic regulatory mechanisms.
Zolk O; Schnepf R; Muschler M; Fromm MF; Wendler O; Traxdorf M; Iro H; Zenk J
Am J Pathol; 2013 Jan; 182(1):234-43. PubMed ID: 23137910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
